Uncategorized
Alimera reports second-quarter net loss of $16.4 million
Alimera Sciences generated $179,000 in the second quarter related to the launch of Iluvien in Germany and the United Kingdom, resulting in a net loss of $16.36 million for the period, according to a news release.The company generated a net loss of $4.7 million in the second quarter of 2012 on no revenues.